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Alzheimer’s disease (AD) is pathologically characterized by the de-
position of extracellular amyloid-β plaques and intracellular aggre-
gation of tau protein in neurofibrillary tangles (NFTs) (1, 2).
Progression of NFT pathology is closely correlated with both in-
creased neurodegeneration and cognitive decline in AD (3) and
other tauopathies, such as frontotemporal dementia (4, 5). The
assumption that mislocalization of tau into the somatodendritic
compartment (6) and accumulation of fibrillar aggregates in NFTs
mediates neurodegeneration underlies most current therapeutic
strategies aimed at preventing NFT formation or disrupting exist-
ing NFTs (7, 8). Although several disease-associated mutations
cause both aggregation of tau and neurodegeneration, whether
NFTs per se contribute to neuronal and network dysfunction in
vivo is unknown (9). Here we used awake in vivo two-photon
calcium imaging to monitor neuronal function in adult rTg4510
mice that overexpress a human mutant form of tau (P301L) and
develop cortical NFTs by the age of 7–8 mo (10). Unexpectedly,
NFT-bearing neurons in the visual cortex appeared to be com-
pletely functionally intact, to be capable of integrating dendritic
inputs and effectively encoding orientation and direction selectiv-
ity, and to have a stable baseline resting calcium level. These results
suggest a reevaluation of the common assumption that insoluble
tau aggregates are sufficient to disrupt neuronal function.
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Neurofibrillary tangles (NFTs) containing aggregated tauprotein (1) have long been considered key players in the
progressive neural dysfunction and neurodegeneration observed
in Alzheimer’s disease (AD) (2, 3) and other tauopathies (4, 5).
It is commonly assumed that NFT-bearing neurons exhibit def-
icits in synaptic integration and eventually lead to neurodegen-
eration (11, 12). However, the actual functional properties of
NFT-bearing neurons in intact neural circuits have not been
explored previously (13). We addressed this question directly
using awake in vivo two-photon calcium imaging in a mouse
model of NFT formation (rTg4510) by applying recently devel-
oped imaging approaches allowing for single-neuron–level and
population-level assessment of neural activity in awake mice (14).
Because two-photon calcium imaging allows for measurement of
response properties in many neurons simultaneously, we were able
to directly isolate the impact of NFT deposition in a neuronal
microcircuit by evaluating population-level network dynamics
and, more specifically, by differentiating the function of individual
NFT-bearing and neighboring non–NFT-bearing neurons.
To assess the functional properties of neurons in the visual
cortex, we used a genetically encoded ratiometric calcium in-
dicator, yellow cameleon 3.6 (YC3.6), packaged in an adeno-
associated viral vector (15, 16). To assess functional responses,
we exploited the well-characterized functional architecture of
visual cortex whereby neurons in mouse visual cortex modulate
their activity during presentation of drifting gratings moving at
specific orientations and directions (orientation and direction
selectivity) (17, 18). We further used YC3.6 as a FRET-based
ratiometric indicator to make quantitative measurements of
resting calcium (15). Resting calcium is tightly regulated in the
brain, and slight deviations can trigger chronic and severe de-
generative pathways (15). Thus, measurement of resting calcium
is an important and complementary functional assay for evaluating
neuronal health. Importantly, performing experiments in awake,
head-fixed animals eliminates the impact of anesthesia on re-
sponse properties, resting calcium, and tau aggregation (Fig. 1 A
and B and Movie S1) (19).
Results
We first confirmed that 8- to 10-mo-old control animals exhibi-
ted robust orientation and direction selectivity, similar to pre-
vious reports in young and aged mice (20) (Fig. 1 and Fig. 2 B–E,
control traces). Average and single trial traces of responses to
visual stimuli measured in a single neuron from a control animal
are shown in Fig. 1C. In this example, the neuron (cell 1) pref-
erentially responds to a visual stimulus orientation of 225° and
has an orientation selectivity index (OSI) of 0.95 and a direction
selectivity index (DSI) of 0.95 (Fig. 1 C, D, and F; 0 indicates no
selectivity, and 1 indicates perfect selectivity).
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We next explored the functional response profiles of neurons
in the visual cortex of transgenic mice with a significant NFT
load in the visual cortex at similar ages to control animals (Fig.
2A and Fig. S1) and compared these profiles with those of
neurons from control brains (Fig. 2 B–E). The rTg4510 mice
exhibited numerous NFTs throughout the cortex, including the
visual cortex (Fig. 2A), along with behavioral deficits typically
seen at this age (10). We observed a marked uniformity in resting
calcium levels across the population of neurons measured in
control mice (Fig. 2B), consistent with previous reports of tightly
regulated resting calcium concentration in the healthy cortex
(15). Neurons in the rTg4510 mice and control mice exhibited
nearly identical resting calcium profiles (control, 1.32; rTg4510,
1.31; cohort-level: P = 0.84, t test, n = 3 rTg4510 mice, n = 3
control mice; cell-specific: P = 0.22, Mann–Whitney U test, n =
898 rTg4510 neurons, n = 329 control neurons) (Fig. 2B).
We further explored whether other cortical brain regions
exhibited disrupted calcium homeostasis by measuring resting
calcium outside of the visual cortex (somatosensory areas), and
found no significant difference (Fig. S2). Moreover, neurons in
mice with a high NFT load exhibited the same robust visual
responses (Fig. 2 C–E) as were observed in controls including
many neurons with sharp orientation and direction selectivity
(OSI: P = 0.47, DSI: P = 0.82, Student t test; n = 6 Tg4510 mice,
n = 6 control mice) (Fig. 2 D and E and Fig. S3). Based on these
data, we conclude that the neuronal network in the visual cortex
of mice with a high NFT load appears to be functionally intact
and comparable to that of control animals.
To examine whether disrupted calcium homeostasis or altered
neuronal tuning in NFT-bearing neurons was masked by aver-
aging the functional properties across all neurons and mice, we
next compared resting calcium regulation and neuronal tuning in
individual neurons with or without NFTs (Fig. 3). To identify
NFT-bearing neurons in the visual cortex of rTg4510 mice, we
aligned images obtained in vivo with images of the same neurons
obtained by postmortem labeling for markers of NFTs (Fig. 3 A–
C) (21). The mice were perfused with paraformaldehyde (PFA)
immediately after completion of in vivo imaging, followed by
postmortem immunolabeling of YC3.6 (with anti-GFP antibody),
hyperphosphoryated tau (with PHF1 antibody), and staining
of mature NFTs using thioflavin-S (ThioS) in whole brains of
rTg4510 mice (Fig. S4). All ThioS-positive NFT-bearing neurons
(n = 32) showed PHF1 labeling of hyperphosphorylated tau, and
very few neurons (n = 6) had hyperphosphorylated tau but no
mature NFTs. For statistical analyses of NFT neuron respon-
siveness, ThioS stained cells were defined as NFT-bearing neu-
rons. In a subset of animals, we also labeled NFTs in vivo using i.v.
injections of the Congo red derivate methoxy-X04 in anesthetized
animals (22, 23) (Fig. S5).
Remarkably, resting calcium (Fig. 3D) and neuronal tuning
(Fig. 3 G and H) were very similar in nearby (and often neigh-
boring) NFT-bearing and non–NFT-bearing neurons from the
same animal and at the same imaging volume. Average resting
calcium levels were nearly identical, and resting calcium dis-
tributions of neighboring NFT-bearing neurons did not exhibit
elevated calcium levels compared with nearby non–NFT-bearing
neurons [n = 13-110 NFT-bearing neurons (per mouse), n = 22-
1006 non-NFT bearing neurons (per mouse), n = 3 mice; P =
0.99 for NFT vs. non-NFT within each animal, Mann-Whitney U
test; P = 0.24 across cohort, paired t test]. In addition, we found
no difference between resting calcium levels in NFT-bearing and
non–NFT-bearing neurons in other areas of the somatosensory
cortex (Fig. S6). For neuronal responsiveness to visual stimuli,
we detected no difference in the probability of response (n= 142
NFT-bearing neurons, n = 1,602 non-NFT-bearing neurons, n =
3 mice; P = 0.39, Student t test), orientation selectivity, or di-
rection selectivity (n = 24 NFT-bearing neurons, n = 122 non–
NFT-bearing neurons, n = 3 mice; OSI, P = 0.38, DSI, P = 0.36,
two-way ANOVA) (Fig. 3 F–H). For OSI and DSI, we per-
formed statistic analyses across the cohort of three animals (Avg)
and for each individual animal (Ms1–Ms3), to reduce any cohort-
level averaging that might have obscured potential differences
(Materials and Methods).
Fig. 1. YC3.6 calcium imaging in awake cortex of control mice reveals robust visual response tuning. (A) Awake and head-fixed mice expressing AAV-YC3.6 in
visual cortex were presented with drifting gratings to record visually evoked calcium responses through a chronic cranial window (Movie S1). (B) In vivo two-
photon image of YC3.6-expressing neurons in layer 2/3 (∼180 μm below the brain surface) with four example neurons (white circles). (Scale bar: 50 μm.) (C)
Drifting gratings (eight stimulus types, 45° apart) were presented for 7–10 s, followed by 7–10 s without stimulation (gray screen). This sequence was repeated
10 times. For cell 1 (orientation- and direction-selective), three representative single-trial time courses (YFP:CFP ratio) and the average trace across 10 trials
reveal its predominant response to a grating direction of 225°. SEM is shown in gray; arrowhead indicates preferred direction. (D) Polar plot of cell 1
demonstrating selectivity of this neuron for the 225° stimuli. (E) Average traces of three other neurons (white circles in A) illustrate the diversity in orientation
and direction tuning. Cell 2 is orientation-selective but not direction-selective, cell 3 responds to all directions (broadly tuned), and cell 4 does not respond to
any direction (not responding). (F) OSI and DSI for cells 1–4.









NFT-bearing neurons are characterized by abnormal accumula-
tion of fibrillar tau aggregates in the cell soma and proximal
dendrites compared with the predominantly axonal localization
of tau in healthy neurons (24). To isolate the consequences of
tau aggregation and mislocalization to soma and dendrites (6),
we focused on the primary visual cortex, a brain area in which the
major driving input source, the lateral geniculate nucleus, is
structurally intact (10, 25) (Fig. S7). We found that in the visual
cortex, neurons containing conspicuous quantities of mislocalized
and aggregated tau nonetheless appear to have a normal capacity
to integrate dendritic inputs and respond robustly to visual stimuli
and also maintain normal somatic baseline calcium levels. In
particular, we show that individual NFT-bearing neurons can re-
spond robustly after integrating sensory inputs and are functionally
indistinguishable from neighboring non–NFT-bearing neurons.
These results demonstrate that NFT-bearing neurons remain
functionally integrated in cortical circuits.
The possibility remains that network elements downstream of
NFT-bearing neurons may show deficits linked to axonal or
presynaptic deficits arising from NFT-bearing neurons. This
property may be particularly relevant in neurons with longer
axonal projections. Moreover, although our findings suggest that
NFT-bearing neurons are capable of integrating sensory inputs,
the possibility exists that a more sensitive assay that challenges
NFT-bearing neurons may reveal subtle alterations in neuronal
function. It also is possible that NFT deposition exerts delete-
rious effects on neural system function at later stages in the
disease; however, similar assays as those used in the present
study have identified dysfunctional phenotypes in amyloid mouse
models with clearly impaired neuronal tuning in animals with
amyloid plaques (20) and profound alterations in baseline resting
calcium levels (15).
In combination with a previous study showing that NFT-
bearing neurons in the hippocampus of rTg4510 mice can induce
expression of the immediate early gene Arc after behavioral
stimulation (26) and another study showing relatively normal
electrophysiological properties in an acute slice preparation (13),
our results strengthen the hypothesis that NFT deposition
resembles an “off-pathway” disease side effect that in itself does
not cause significant disruption of network function (9, 10, 13,
27–29). Mouse models are inherently limited in their ability to
capture all aspects of adult human AD because of differences in
pathology structure, kinetics, and distribution. Future work will
need to explore the longitudinal impact of tau deposition on
single-neuron, local circuit, and neural system function: how
neurons and networks change before, during, and after NFT
deposition, and how prefibrillar and soluble oligomeric tau
aggregates impact neuronal function. These types of studies will
benefit greatly from new in vivo staining compounds that dif-
ferentially bind soluble, prefibrillar, and aggregated tau. Even
within these limitations, however, our present findings call into
question therapeutic strategies aimed at preventing or disrupting
fibrillar tau deposits (30), which may indeed sequester more
toxic soluble tau species (31, 32).
Materials and Methods
Animals. All experiments were performed using 8- to 10-mo-old transgenic
rTg4510 mice overexpressing full-length human four-repeat tau (0N4R)
carrying the frontotemporal dementia-associated P301L mutation (10). By
age 7–8 mo, rTg4510 mice had developed a large number of NFTs in the
cortex. Control animals lacked the human tau transgene.
Fig. 2. The visual cortex of mice with a severe NFT load appears functionally intact. (A) Coronal brain sections demonstrate human tau protein expression
(immunolabeled with Tau13) and severe NFT deposition (ThioS) in the visual cortex of rTg4510 mice (Right), but not of control mice (Left), at age 9 mo. (B)
Distributions of average resting calcium levels (YFP:CFP ratios) determined from the time intervals between stimuli reveal no significant difference (P = 0.84,
t test) between control mice (n = 3) and rTg4510 mice (n = 3). Moreover, there is no significant difference when comparing at a cell-specific level (P = 0.22,
Mann–Whitney U test; n = 898 rTg4510 cells, n = 329 control cells). (C) Neurons in visual cortex layer 2/3 of both control and NFT-loaded rTg4510 mice show
robust direction preferences (DSI >0.5). Pseudocolors denote the preferred stimulus direction of tuned cells; noncolored cells were not responsive or broadly
tuned. (Scale bar: 50 μm.) (D and E) Distributions of OSI (D) and DSI (E) show no significant difference between orientation selectivity (OSI: P = 0.47, t test) and
direction selectivity (DSI: P = 0.82, t test) of responding neurons from rTg4510 mice (n = 6) with a high NFT load and control mice (n = 6). Dashed lines indicate
cumulative probabilities.
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Surgical Procedures. A small craniotomy was performed over the visual cortex
(15, 33). An adeno-associated virus (AAV) vector encoding the ratiometric
calcium indicator YC3.6 (AAV8-CBA-YC3.6; Penn Vector Core) was stereo-
tactically injected for expression of YC3.6 in layer 2/3 neurons in the right
primary visual cortex V1 (from lambda: +0.5 mm anteroposterior, 2.7 mm
lateral, 0.6 mm dorsoventral). Above the injection coordinates, a cranial
window was implanted replacing a circular piece (3 mm diameter) of skull by
a glass coverslip that was secured in place using a mix of dental cement and
Krazy Glue. A custom-made stainless-steel headpost (Ponoko) was affixed to
the skull using C&B Metabond dental cement (Parkell), and each animal was
allowed to recover for at least 2–3 wk. Before imaging, animals were ha-
bituated to the custom-made head-fixation device (Thorlabs posts and Altos
head clamps), during which they were allowed to run freely on a circular
treadmill (Ponoko).
In Vivo Calcium Imaging. Two-photon fluorescence of YC3.6 was excited at
860 nm using a mode-locked Ti:sapphire laser (MaiTai; Spectra Physics) and
detected in the blue channel (CFP emission) and the yellow channel (YFP
emission). Imaging was performed with a multiphoton imaging system
(Fluoview1000; Olympus) equipped with a water immersion objective (25×,
NA = 1.05; Olympus), with the emission path shielded from external light
contamination. To record time courses of visually stimulated neuronal ac-
tivity-dependent calcium levels, awake animals were head-fixed under the
microscope, and an LCD monitor displaying the visual stimuli was placed in
front of the left eye (screen–eye distance, ∼20 cm; screen-midline angle, 60°).
Visual stimuli were drifting (2 Hz) sine-wave gratings (80% or 100% contrast,
black and white) presented for ∼7 s. Stimuli were presented at 60 Hz
using a calibrated 19-inch LCD monitor (Viewsonic VP930B). Eight stimuli
(at 45° orientation increments) were presented sequentially in counter-
clockwise order with ∼7 s between stimuli. During visual stimulation, several
∼300 μm2 areas in layer 2/3 of V1 containing multiple YC3.6-expressing
neurons were selected and imaged (scan rate, ∼2.5 Hz, 0.429 s/frame; laser
power, ≤50 mW).
Image Processing and Data Analysis. Semiautomated data analysis was per-
formed using custom-written software in ImageJ (National Institutes of
Health) and MATLAB (MathWorks). Images were aligned for minor shifts in
the x-y plane owing to movement, cellular regions of interest (ROI) were
manually drawn, YFP:CFP ratios were created and spatially filtered, and raw




Fig. 3. NFT-bearing neurons exhibit normal visual response properties. (A) In vivo imaging sites were coregistered with postmortem images obtained from
cleared brains in which neurons were labeled for YC3.6 (immunolabeled with anti-GFP) and NFTs (staining with ThioS; detailed workflow in Fig. S4). (B) In vivo
image showing neighboring NFT-free (blue) and NFT-bearing (red) neurons, including two visually responsive neurons (white circles). (Scale bar: 50 μm.) (C)
The presence of NFTs (white arrowheads) was identified based on postmortem NFT staining in clear brain. (Scale bar: 50 μm.) (D) Resting calcium distributions
of non–NFT-bearing and NFT-bearing neurons in the visual cortex show no significant difference [cohort-level, paired t test, n = 3 mice; P = 0.24; intra-animal,
Mann-Whitney U test right-sided, n = 13-110 NFT-bearing neurons (per mouse), n = 22-1006 non-NFT bearing neurons (per mouse), P = 0.99]. (E) Average
response traces of a broadly tuned non–NFT-bearing neuron and an NFT-bearing neuron (white circles in B and C labeled 1 and 2, respectively). (F) The
average percentage of responding neurons (mean ± SEM) was not significantly different between non–NFT-bearing (blue, 1602 cells) and NFT-bearing (red,
142 cells) neurons (P = 0.4, Student t test; n = 3 mice), but was highly variable among mice (Ms1–Ms3). (G and H) Average (mean ± SEM) OSI (G) and DSI (H) of
non–NFT-bearing (blue) and NFT-bearing (red) neurons, analyzed across all mice (Avg) and for intramouse comparisons (Ms1–Ms3) (two-way ANOVA with
Tukey–Cramer post hoc test; n = 24 NFT-bearing neurons, n = 122 non–NFT-bearing neurons; 3 mice; OSI: P = 0.4 for NFT, P = 0.3 for interaction; DSI: P = 0.4
for NFT, P = 0.3 for interaction).








shift in the z-axis (rare; <5% of all time courses). For each cellular ROI, the
change in directional response (ΔR; R − Rnonstimulated) was compared across
directions and against background, and “responsive” cells were identified
(P < 0.05, ANOVA with the Tukey–Cramer post hoc test and Bonferonni
correction). Only responsive cells were used for further analysis of orienta-
tion and direction tuning.
The OSI and DSI were calculated as described previously (34). In short, OSI
was calculated as the maximum directional response, ΔRmax, divided by the
sum of responses in all other directions, ΣΔRother (0 ≤ OSI ≤ 1; 1 = perfectly
orientation-tuned). DSI was calculated as ΔRmax divided by the sum of that
direction and the antiparellel direction, ΔRmaxr+ ΔRorthogonal (0 ≤ DSI ≤ 1;
1 = perfectly direction-tuned).
Statistical Analysis. All statistical analyses were performed in MATLAB. All
datasets were first tested for normality (Lilliefors test), after which appro-
priate statistical tests were applied (e.g., t test/two-way ANOVA for normally
distributed data, Mann–Whitney U test for nonparametric data). For com-
parisons of NFT versus non-NFT neuronal tuning in Fig. 3, two-way ANOVA
was used to explore fixed effects due to interanimal and intra-animal dif-
ferences. Data were analyzed by cell, grouped by mouse (i.e., Ms1, Ms2, or
Ms3) and the presence of NFTs (i.e., NFT-bearing or non–NFT-bearing). For
cohort-level analyses, the P value for the NFT group was used. For intra-
animal comparisons, the interaction term was used (mouse × NFT presence)
and the Tukey–Cramer post hoc test was used to explore intra-animal
comparisons of NFT vs. non-NFT. The average P value for intraanimal com-
parisons of OSI and DSI was highly insignificant, P = 0.47.
Postmortem Whole-Brain Staining, Brain Clearing, and In Vivo Correlations. In
a subset of rTg4510 mice, postmortem identification of NFTs was achieved
using whole brain immunostaining followed by brain “clearing” (21). Im-
mediately after in vivo recording of calcium levels, mice were perfused with
4% PFA in PBS, and brains were postfixed in 4% PFA for 1–2 d and then
stored in 0.25% PFA at 4 °C. Whole brains were permeabilized and blocked
in PBS containing 2% Triton-X100, 1% BSA, and 5% normal goat serum
(NGS) for 5 h at room temperature. To immunolabel YC3.6-expressing cells
and neurons with hyperphosphorylated tau, brains were incubated with
primary antibodies [chicken anti-GFP (Invitrogen, 1:250) and mouse PHF1
(1:250)] in PBS containing 1% Triton, 1% BSA, and 2% NGS at 4 °C for 10 d.
Secondary antibodies [goat anti-chicken Alexa Fluor 488 and goat anti-
mouse Alexa Fluor 594 (Invitrogen, 1:250)] were applied for 7 d at 4 °C. For
clearing, brains were stepwise saturated with glycerol by incubation in
80:20, 60:40, 40:60, and 20:80 PBS %:glycerol % for 5 h each at room tem-
perature. Final clearing was achieved by incubation in a clearing solution of
53% benzyl alcohol, 45% glycerol, and 2% DABCO (wt/wt) for 10 d at room
temperature. Clear brain multiphoton imaging (excitation λ = 800 nm) of
previously in vivo imaged cells allowed for single cell reconstruction and
correlation of PHF1-positive cells with measured calcium levels. To label
mature NFTs, clear brains were then incubated in clearing solution con-
taining 0.025% ThioS for 2 d at room temperature, followed by reclearing
in clearing solution for 3 d. Reimaging the same cortical areas enabled re-
construction of NFT positions in in vivo images and correlation with
calcium responses.
Immunolabeling of Visual Cortex Sections. Eight- to 9-mo-old rTg4510 and
control mice were perfused with 4% PFA in PBS. Brains were postfixed in 4%
PFA for 1–2 d at 4 °C, incubated for 2 d in 30% sucrose in PBS for cry-
oprotection, and then cut into 50-μm-thick coronal sections. Sections con-
taining visual cortex were permeabilized with Triton-X100 in PBS, blocked in
5% NGS in PBS, and incubated in primary antibody [mouse anti-human tau
(TAU-13; Abcam, 1:1,000)] in 5% NGS in PBS overnight at 4 °C. Secondary
antibody [goat anti-mouse Cy3 (Invitrogen, 1:1,000)] was applied in 5% NGS
in PBS for 1 h at room temperature. After washing in PBS, brain slices were
mounted on microscope slides, and NFTs were stained with 0.025% ThioS in
50% ethanol for 8 min. ThioS was differentiated in 80% ethanol for 30s,
sections were washed with water for 3 min, and coverslips were mounted
using DAPI containing mounting medium (Vectashield).
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